Eli Lilly Stock Jumps on Earnings Beat as Zepbound and Mounjaro Sales Skyrocket
Yahoo Finance1 min read
Read Full Article at Yahoo Finance →Ad Slot — In-Article (728x90)
FEATURE Shares of Eli Lilly rose sharply on Thursday after the drugmaker delivered a beat-and-raise quarter driven partly by demand for its GLP-1 drugs. First-quarter adjusted earnings of $8. 55 a share handily beat the $6.
This is a summary. For the full story, read the original article at Yahoo Finance.
Original source: Yahoo Finance